News Release

USPSTF recommendation on aspirin use to prevent preeclampsia


Peer-Reviewed Publication

JAMA Network

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends the use of low-dose aspirin (81mg/d) as preventive medication for preeclampsia after 12 weeks of gestation in individuals who are at high risk for preeclampsia. A multisystem inflammatory syndrome that is often progressive, preeclampsia is one of the most serious health problems that affect pregnant individuals. It is a complication in approximately 4 percent of pregnancies in the United States. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this statement updates and is consistent with its 2014 recommendation and is strengthened by new evidence from additional trials demonstrating reduced risks of perinatal death with low-dose aspirin use.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at or call 301-951-9203. 

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.